EPHX1 overexpression has been observed in other human malignancies, including liver cancer, lung cancer, and breast cancer (Spurdle et al., 2007; Tilak et al., 2011; Yu et al., 2015; Sun et al., 2020). This evidence concerns the gene EPHX1 and lung carcinoma.